B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Neratinib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Neratinib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

pelitinib
66 shared targets
bosutinib
87 shared targets
tozasertib
79 shared targets
foretinib
75 shared targets
kw
95 shared targets
tae
97 shared targets
nintedanib
79 shared targets
su
83 shared targets
canertinib
50 shared targets
cediranib
44 shared targets
Loading evidence profile...

This evidence profile for Neratinib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.